<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37986044</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2731-4553</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC primary care</Title><ISOAbbreviation>BMC Prim Care</ISOAbbreviation></Journal><ArticleTitle>The cost of primary care consultations associated with long COVID in non-hospitalised adults: a retrospective cohort study using UK primary care data.</ArticleTitle><Pagination><StartPage>245</StartPage><MedlinePgn>245</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">245</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12875-023-02196-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">The economic impact of managing long COVID in primary care is unknown. We estimated the costs of primary care consultations associated with long COVID and explored the relationship between risk factors and costs.</AbstractText><AbstractText Label="METHODS">Data were obtained on non-hospitalised adults from the Clinical Practice Research Datalink Aurum primary care database.&#xa0;We used propensity score matching with an incremental cost method to estimate additional primary care consultation costs associated with long COVID (12&#xa0;weeks after&#xa0;COVID-19) at an individual and UK national level. We applied multivariable regression models to estimate the association between risk factors and consultations costs beyond 12&#xa0;weeks from acute COVID-19.</AbstractText><AbstractText Label="RESULTS">Based on an analysis of 472,173 patients with COVID-19 and 472,173 unexposed individuals, the annual incremental cost of primary care consultations associated with long COVID was &#xa3;2.44 per patient and &#xa3;23,382,452&#xa0;at the national level. Among patients with COVID-19, a long COVID diagnosis and reporting of longer-term&#xa0;symptoms were associated with a 43% and 44% increase in primary care consultation costs respectively, compared to patients without long COVID symptoms.&#xa0;Older age, female sex, obesity, being from a white ethnic group, comorbidities and prior consultation frequency were all associated with increased primary care consultation costs.</AbstractText><AbstractText Label="CONCLUSIONS">The costs of primary care consultations&#xa0;associated with long COVID in non-hospitalised adults are substantial. Costs are significantly higher among those diagnosed with long COVID, those with long COVID symptoms,&#xa0;older adults, females, and those with obesity and comorbidities.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tufts</LastName><ForeName>Jake</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospitals of Morecambe Bay NHS Foundation Trust, Lancashire, LA9 7RG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Naijie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. n.guan@bham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zemedikun</LastName><ForeName>Dawit T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>School of Population and Global Health (M431), The University of Western Australia, 35 Stirling Highway, Perth, WA, 6009, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Anuradhaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gokhale</LastName><ForeName>Krishna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Puja</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, E14 4PU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, E14 4PU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvert</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied Research Collaboration (ARC) West Midlands, National Institute for Health Research (NIHR), Birmingham, CV4 7AJ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospital Birmingham and University of Birmingham, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham-Oxford Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matthews</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Long Covid SOS, Charity Registered in England &amp; Wales, 11A Westland Road, Faringdon, SN7 7EX, Oxfordshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nirantharakumar</LastName><ForeName>Krishnarajah</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jackson</LastName><ForeName>Louise J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Haroon</LastName><ForeName>Shamil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_20050</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Prim Care</MedlineTA><NlmUniqueID>9918300889006676</NlmUniqueID><ISSNLinking>2731-4553</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cost</Keyword><Keyword MajorTopicYN="N">Economic</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Primary care</Keyword></KeywordList><CoiStatement>All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: JT has no relevant conflicts of interest to declare. DTZ has no relevant conflicts of interest to declare. AS has no relevant conflicts of interest to declare. NG has no relevant conflicts of interest to declare. KG has no relevant conflicts of interest to declare. KN has no relevant conflicts of interest to declare. LJ has no relevant conflicts of interest to declare. SH receives research funding from the NIHR and UKRI. PM has no relevant conflicts of interest to declare. TM has no relevant conflicts of interest to declare. TW has not relevant conflicts of interest. KM has no relevant conflicts of interest. MJC is director of the Birmingham Health Partners Centre for Regulatory Science and Innovation and director of the Centre for Patient Reported Outcomes Research and is an NIHR senior investigator. MJC receives funding from the NIHR, UKRI, NIHR Birmingham Biomedical Research Centre, NIHR Surgical Reconstruction and Microbiology Research Centre, NIHR ARC West Midlands, NIHR Oxford-Birmingham Blood and Transplant Research Unit in Precision and Cellular Therapeutics, UK SPINE, European Regional Development Fund-Demand Hub and Health Data Research UK at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB Pharma, Janssen, GlaxoSmithKline, and Gilead. MJC has received personal fees from Astellas, Aparito, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GlaxoSmithKline, and the Patient-Centered Outcomes Research Institute outside the submitted work. In addition, a family member owns shares in GlaxoSmithKline.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>21</Day><Hour>2</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37986044</ArticleId><ArticleId IdType="pmc">PMC10662438</ArticleId><ArticleId IdType="doi">10.1186/s12875-023-02196-1</ArticleId><ArticleId IdType="pii">10.1186/s12875-023-02196-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation (WHO). A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. 2021 Oct 06. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Cited 22/04/2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE. 2022 Mar 01. Available at: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742#:~:text=In%20addition%20to%20the%20clinical,(12%20weeks%20or%20more). Cited 12/04/2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 map. Johns Hopkins Coronavirus Resource Centre. Available from: https://coronavirus.jhu.edu/map.html. Cited 2022 Nov 20.</Citation></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;15. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 7 July 2022. 7 Jul 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7july2022. Cited 13/07/2022.</Citation></Reference><Reference><Citation>Whittaker HR, Gulea C, Koteci A, Kallis C, Morgan AD, Iwundu C, Weeks M, Gupta R, Quint JK. GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population-based study. BMJ. 2021;29:375. doi: 10.1136/bmj-2021-065834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-065834</ArticleId><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale K, Taverner T, Chandan J, Brown K, Simms-Williams N, Shah A. Assessment of 115 symptoms for Long COVID (post-COVID-19 condition) and their risk factors in non-hospitalised individuals: a retrospective matched cohort study in UK primary care. 10.21203/rs.3.rs-1343889/v1.</Citation></Reference><Reference><Citation>Rice DP. Estimating the cost of illness. American J Pub Health Nation&#x2019;s Health. 1967;57(3):424&#x2013;440. doi: 10.2105/AJPH.57.3.424.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.57.3.424</ArticleId><ArticleId IdType="pmc">PMC1227175</ArticleId><ArticleId IdType="pubmed">6066903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. The Milbank memorial fund quarterly. Health Soc. 1982;60:429&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">6923138</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan D, Yeh ST, O&#x2019;Neill C, Frick KD. Evaluating direct medical expenditures estimation methods of adults using the medical expenditure panel survey: an example focusing on head and neck cancer. Value in Health. 2014;17(1):90&#x2013;97. doi: 10.1016/j.jval.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2013.10.004</ArticleId><ArticleId IdType="pubmed">24438722</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon S, Nirantharakumar K, Hughes SE, Subramanian A, Aiyegbusi OL, Davies EH, Myles P, Williams T, Turner G, Chandan JS, McMullan C. Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study) BMJ Open. 2022;12(4):e060413. doi: 10.1136/bmjopen-2021-060413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-060413</ArticleId><ArticleId IdType="pmc">PMC9044550</ArticleId><ArticleId IdType="pubmed">35473737</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Practice Research Datalink. (2021). CPRD Aurum June 2021 (Version 2021.06.001). Clinical Practice Research Datalink. 10.48329/pyc2-we97.</Citation></Reference><Reference><Citation>Wolf A, Dedman D, Campbell J, Booth H, Lunn D, Chapman J, Myles P. Data resource profile: clinical practice research Datalink (CPRD) aurum. Int J Epidemiol. 2019;48(6):1740-g. doi: 10.1093/ije/dyz034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz034</ArticleId><ArticleId IdType="pmc">PMC6929522</ArticleId><ArticleId IdType="pubmed">30859197</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Digital. SNOMED CT. 2022 Jun 29. Available from: URL: https://digital.nhs.uk/services/terminology-and-classifications/snomed-ct. Cited 29/07/2022.</Citation></Reference><Reference><Citation>Gokhale KM, Chandan JS, Toulis K, Gkoutos G, Tino P, Nirantharakumar K. Data extraction for epidemiological research (dExtER): a novel tool for automated clinical epidemiology studies. Eur J Epidemiol. 2021;36(2):165&#x2013;178. doi: 10.1007/s10654-020-00677-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00677-6</ArticleId><ArticleId IdType="pmc">PMC7987616</ArticleId><ArticleId IdType="pubmed">32856160</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using opensafely. Br J Gen Pract. 2021;71(712):e806&#x2013;e814. doi: 10.3399/BJGP.2021.0301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0301</ArticleId><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;vesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340(mar12 1):b5087. doi: 10.1136/bmj.b5087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b5087</ArticleId><ArticleId IdType="pubmed">20228141</ArticleId></ArticleIdList></Reference><Reference><Citation>Personal Social Services Unit. Unit Costs of Health and Social Care 2021. 2022 Jan 31. 10.22024/UniKent/01.02.92342. Cited 22/04/2022.</Citation></Reference><Reference><Citation>Wang HI, Han L, Jacobs R, Doran T, Holt RI, Prady SL, Gilbody S, Shiers D, Alderson S, Hewitt C, Taylor J. Healthcare resource use and costs for people with type 2 diabetes mellitus with and without severe mental illness in England: longitudinal matched-cohort study using the clinical practice research Datalink. Br J Psychiatry. 2021;221(1):402&#x2013;409. doi: 10.1192/bjp.2021.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2021.131</ArticleId><ArticleId IdType="pubmed">35049484</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus (COVID-19) Infection Survey technical article: Cumulative incidence of the number of people who have tested positive for COVID-19, UK - Office for National Statistics. Gov.uk. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticlecumulativeincidenceofthenumberofpeoplewhohavetestedpositiveforcovid19uk/22april2022. Cited 2022 Nov 20.</Citation></Reference><Reference><Citation>UK Health Security Agency. Coronavirus (COVID-19) in the UK: Cases in England. Gov.uk. Available from: https://coronavirus.data.gov.uk/details/cases?areaType=nation&amp;areaName=England. Cited on 27 October 2023.</Citation></Reference><Reference><Citation>Koumpias AM, Schwartzman D, Fleming O. Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis. BMC Health Serv Res. 2022;22(1):1010. doi: 10.1186/s12913-022-08387-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-08387-3</ArticleId><ArticleId IdType="pmc">PMC9358916</ArticleId><ArticleId IdType="pubmed">35941617</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Moreno J, Ju&#xe1;rez-Vela R, Delgado-Rodr&#xed;guez MJ, Quintana-D&#xed;az M, Magall&#xf3;n-Botaya R, Olivan-Bl&#xe1;zquez B, et al. Approximation to the consumption of healthcare resources and the economic cost of SARS-CoV-2 patient management: a retrospective study. Front Pub Health. 2022;10:843751. doi: 10.3389/fpubh.2022.843751.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.843751</ArticleId><ArticleId IdType="pmc">PMC9008573</ArticleId><ArticleId IdType="pubmed">35433597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanat M, Hoste M, Gobat N, Anastasaki M, B&#xf6;hmer F, Chlabicz S, Colliers A, Farrell K, Karkana MN, Kinsman J, Lionis C. Transformation of primary care during the COVID-19 pandemic: experiences of healthcare professionals in eight European countries. Br J Gen Pract. 2021;71(709):e634&#x2013;e642. doi: 10.3399/BJGP.2020.1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2020.1112</ArticleId><ArticleId IdType="pmc">PMC8274627</ArticleId><ArticleId IdType="pubmed">33979303</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotubo OA. A perspective on health inequalities in BAME communities and how to improve access to primary care. Future Healthc J. 2021;8(1):36&#x2013;9. doi: 10.7861/fhj.2020-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/fhj.2020-0217</ArticleId><ArticleId IdType="pmc">PMC8004339</ArticleId><ArticleId IdType="pubmed">33791458</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430&#x2013;436. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatle M. COVID-19 highlights health inequalities in individuals from black and minority ethnic backgrounds within the United Kingdom. Health Promot Perspect. 2021;11(2):115&#x2013;6. doi: 10.34172/hpp.2021.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/hpp.2021.15</ArticleId><ArticleId IdType="pmc">PMC8233673</ArticleId><ArticleId IdType="pubmed">34195034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gbadamosi J, Siddiqui F, Thakar R. Healthcare inequalities in Black, Asian and ethnic minority groups: digging beneath the surface. Obstet Gynaecol. 2022;24(3):156&#x2013;158. doi: 10.1111/tog.12817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tog.12817</ArticleId></ArticleIdList></Reference><Reference><Citation>McGreevy A, Soley-Bori M, Ashworth M, Wang Y, Rezel-Potts E, Durbaba S, et al. Ethnic inequalities in the impact of COVID-19 on primary care consultations: a time series analysis of 460,084 individuals with multimorbidity in South London. BMC Med. 2023;21(1):1&#x2013;4. doi: 10.1186/s12916-022-02720-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02720-7</ArticleId><ArticleId IdType="pmc">PMC9851584</ArticleId><ArticleId IdType="pubmed">36658550</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekezie W, Maxwell A, Byron M, Czyznikowska B, Osman I, Moylan K, et al. Health communication and inequalities in primary care access during the COVID-19 pandemic among ethnic minorities in the United Kingdom: Lived experiences and recommendations. Int J Environ Res Public Health. 2022;19(22):15166. doi: 10.3390/ijerph192215166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192215166</ArticleId><ArticleId IdType="pmc">PMC9690007</ArticleId><ArticleId IdType="pubmed">36429886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazroo JY, Falaschetti E, Pierce M, Primatesta P. Ethnic inequalities in access to and outcomes of healthcare: analysis of the Health Survey for England. J Epidemiol Community Health. 2009;63(12):1022&#x2013;1027. doi: 10.1136/jech.2009.089409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2009.089409</ArticleId><ArticleId IdType="pubmed">19622520</ArticleId></ArticleIdList></Reference><Reference><Citation>Akobundu E, Ju J, Blatt L, Mullins CD. Cost-of-illness studies. Pharmacoeconomics. 2006;24(9):869&#x2013;890. doi: 10.2165/00019053-200624090-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-200624090-00005</ArticleId><ArticleId IdType="pubmed">16942122</ArticleId></ArticleIdList></Reference><Reference><Citation>Balu S, Thomas J. Incremental expenditure of treating hypertension in the United States. Am J Hypertens. 2006;19(8):810&#x2013;816. doi: 10.1016/j.amjhyper.2005.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjhyper.2005.12.013</ArticleId><ArticleId IdType="pubmed">16876679</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopfert A, Deeny SR, Fisher R, Stafford M. Primary care consultation length by deprivation and multimorbidity in England: an observational study using electronic patient records. Br J Gen Pract. 2021;71(704):e185&#x2013;e192. doi: 10.3399/bjgp20X714029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp20X714029</ArticleId><ArticleId IdType="pmc">PMC7744040</ArticleId><ArticleId IdType="pubmed">33318089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AC, English P, Pankhania B, Morling JR. Where Englan&#x2019;'s pandemic response to COVID-19 went wrong. Public Health. 2021;192:45. doi: 10.1016/j.puhe.2020.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2020.11.015</ArticleId><ArticleId IdType="pmc">PMC7680038</ArticleId><ArticleId IdType="pubmed">33631513</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid-an update for primary care. BMJ. 2022;378:e072117. doi: 10.1136/bmj-2022-072117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>